Kiniksa Pharmaceuticals Intern - COM (KNSA)

Historical Holders from Q2 2018 to Q3 2025

Symbol
KNSA on Nasdaq
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
50,700
Holdings value
$1,968,900
% of all portfolios
0%
Number of holders
2
Number of sells
-1
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 50,700 $1,968,900 -$1,950,807 $38.84 2
2025 Q2 100,926 $2,793,100 -$188,257 $27.67 2
2025 Q1 107,728 $2,392,444 -$452,253 $22.21 2
2024 Q4 128,093 $2,533,400 +$10,877 $19.78 2
2024 Q3 127,543 $3,187,700 +$1,752,103 $24.99 2
2024 Q2 66,788 $1,245,997 -$764,968,495 $18.66 5
2024 Q1 38,915,007 $767,771,992 +$97,416,660 $19.73 152
2023 Q4 34,230,910 $600,390,420 -$23,838,881 $17.54 141
2023 Q3 34,876,487 $605,788,469 +$53,667,586 $17.37 134
2023 Q2 31,784,664 $447,526,181 +$7,927,431 $14.08 124
2023 Q1 31,540,540 $339,374,716 +$13,098,378 $10.76 129
2022 Q4 29,821,897 $446,643,807 +$8,492,661 $14.98 123
2022 Q3 29,944,096 $383,463,101 +$7,943,628 $12.84 102
2022 Q2 29,927,164 $290,480,832 -$6,832,587 $9.69 89
2022 Q1 30,780,072 $305,983,391 +$11,819,146 $9.94 93
2021 Q4 29,433,678 $346,422,270 +$3,332,219 $11.77 99
2021 Q3 29,118,377 $331,680,458 -$3,575,240 $11.39 97
2021 Q2 28,854,977 $401,952,759 -$18,013,419 $13.93 100
2021 Q1 29,045,474 $537,618,213 -$12,626,294 $18.51 103
2020 Q4 29,771,513 $526,065,708 +$27,474,840 $17.67 107
2020 Q3 28,297,751 $433,552,379 +$112,164,880 $15.32 100
2020 Q2 21,136,667 $538,561,145 +$102,084,479 $25.48 93
2020 Q1 17,688,582 $273,807,295 +$42,268,055 $15.48 73
2019 Q4 15,111,735 $167,132,797 -$17,619 $11.06 59
2019 Q3 15,536,009 $132,209,858 -$16,950,084 $8.51 52
2019 Q2 16,517,277 $223,640,811 +$1,318,575 $13.54 60
2019 Q1 16,320,532 $294,745,491 +$33,902,513 $18.06 56
2018 Q4 13,718,342 $385,346,124 -$47,585,553 $28.09 52
2018 Q3 14,420,950 $363,005,519 -$79,063,573 $25.5 54
2018 Q2 17,262,299 $297,816,000 +$297,816,030 $17.35 41